GAMA
ADAP
Graticule Asia Macro Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-346,500
| Closed | -$1.84M | – | 118 |
|
|
2021
Q1 | $1.84M | Sell |
346,500
-134,784
| -28% | -$716K | 0.31% | 89 |
|
|
2020
Q4 | $2.59M | Buy |
481,284
+297,804
| +162% | +$1.61M | 1.24% | 27 |
|
|
2020
Q3 | $1.46M | Buy |
+183,480
| New | +$1.46M | 0.14% | 39 |
|
|
2018
Q4 | – | Sell |
-185,000
| Closed | -$2.51M | – | 82 |
|
|
2018
Q3 | $2.51M | Buy |
185,000
+105,000
| +131% | +$1.42M | 0.14% | 69 |
|
|
2018
Q2 | $950K | Sell |
80,000
-336,457
| -81% | -$4M | 0.06% | 83 |
|
|
2018
Q1 | $4.68M | Sell |
416,457
-232,188
| -36% | -$2.61M | 0.5% | 25 |
|
|
2017
Q4 | $4.33M | Buy |
648,645
+252,821
| +64% | +$1.69M | 0.8% | 18 |
|
|
2017
Q3 | $3.24M | Buy |
+395,824
| New | +$3.24M | 0.15% | 52 |
|
|
2016
Q1 | – | Sell |
-50,000
| Closed | -$603K | – | 46 |
|
|
2015
Q4 | $603K | Buy |
+50,000
| New | +$603K | 0.1% | 142 |
|